Lassa fever belongs to the same class of hemorrhagic fevers as Ebola. Like Ebola, it has been a major health threat in Western Africa, infecting 100,000-300,000 people and killing 5,000 per year. A new vaccine against both ...
Oct 11, 2018
0
35
Researchers at The University of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety ...
Oct 5, 2018
0
48
More lives have been saved by vaccines than any public health initiative, save clean water – yet millions of people worry that vaccines are a threat to themselves and their children. Such fears result in vaccination rates ...
Oct 1, 2018
0
2
New research published in The Lancet shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys. Moreover, the ...
Jul 7, 2018
1
1916
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...
Jun 4, 2018
0
458
It's a question that has challenged scientists and physicians for years: Why do vaccines work better in some parts of the world than in others? A new study, led in part by University of Minnesota Medical School researcher ...
May 29, 2018
1
263
The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries. This new policy will help ensure access to typhoid ...
Apr 3, 2018
0
21
When biomolecular engineer Phil Berman began his postgraduate work in the 1980s, he had no idea he would spend the rest of his career searching for a way to stop a deadly virus that was then almost entirely known. But around ...
Feb 19, 2018
0
10
Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinical trials. One reason for this is the technical ...
Feb 5, 2018
0
5
Researchers at Baylor College of Medicine, in collaboration with a team of researchers at the George Washington University and the Rene Rachou Institute, have received funding from the National Institutes of Health for a ...
Jan 18, 2018
0
2
